PFIZER INC Restructuring Reserve, Period Increase (Decrease)
PFIZER INC (PFE) reported Restructuring Reserve, Period Increase (Decrease) of $106.00 million for the 6-month period ending 2014-06-29, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodIncreaseDecrease · last filed 2014-08-07
- PFIZER INC restructuring reserve, period increase (decrease) for the quarter ending 2014-06-29 was $66.00M, a 54.79% decline year-over-year.
- PFIZER INC restructuring reserve, period increase (decrease) for the quarter ending 2014-03-30 was $40.00M, a 59.60% decline year-over-year.
- PFIZER INC restructuring reserve, period increase (decrease) for the quarter ending 2013-12-31 was $598.00M, a 5.83% decline year-over-year.
- PFIZER INC restructuring reserve, period increase (decrease) for the quarter ending 2013-09-29 was $195.00M, a 9.30% decline year-over-year.
- PFIZER INC restructuring reserve, period increase (decrease) for fiscal 2013 was $1.04B, a 27.31% decline from fiscal 2012.
- PFIZER INC restructuring reserve, period increase (decrease) for fiscal 2012 was $1.43B, a 34.34% decline from fiscal 2011.
- PFIZER INC restructuring reserve, period increase (decrease) for fiscal 2011 was $2.17B.
| Period end | Restructuring Reserve, Period Increase (Decrease) 3 month | Restructuring Reserve, Period Increase (Decrease) 6 month | Restructuring Reserve, Period Increase (Decrease) 9 month | Restructuring Reserve, Period Increase (Decrease) 12 month | Restructuring Reserve, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2014-06-29 | $66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $106.00M 10-Q · filed 2014-08-07 | $704.00M derived: sum of 3 quarters · filed 2014-08-07 | $899.00M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2014-03-30 | $40.00M 10-Q · filed 2014-05-08 | $638.00M derived: sum of 2 quarters · filed 2014-05-08 | $833.00M derived: sum of 3 quarters · filed 2014-05-08 | $979.00M derived: sum of 4 quarters · filed 2014-05-08 | |
| 2013-12-31 | $598.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $793.00M derived: sum of 2 quarters · filed 2014-02-28 | $939.00M derived: sum of 3 quarters · filed 2014-02-28 | $1.04B 10-K · filed 2014-02-28 | |
| 2013-09-29 | $195.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $341.00M derived: sum of 2 quarters · filed 2013-11-08 | $440.00M 10-Q · filed 2013-11-08 | $1.07B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2013-06-30 | $146.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $245.00M 10-Q · filed 2013-08-09 | $880.00M derived: sum of 3 quarters · filed 2014-02-28 | $1.09B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2013-03-31 | $99.00M 10-Q · filed 2013-05-10 | $734.00M derived: sum of 2 quarters · filed 2014-02-28 | $949.00M derived: sum of 3 quarters · filed 2014-02-28 | ||
| 2012-12-31 | $635.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $850.00M derived: sum of 2 quarters · filed 2014-02-28 | $1.43B 10-K · filed 2014-02-28 | $1.47B 10-K · filed 2013-02-28 | |
| 2012-09-30 | $215.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $793.00M 10-Q · filed 2012-11-09 | |||
| 2012-07-01 | $578.00M 10-Q · filed 2012-08-09 | ||||
| 2011-12-31 | $2.17B 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |